NCID and I-DAIR pledge to jointly foster digital health solutions
Today, the International Digital Health & AI Research Collaborative (I-DAIR) and the National Centre for Infectious Diseases (NCID) of Tan Tock Seng Hospital (TTSH), in Singapore, signed a Memorandum of Understanding (MoU) establishing a basis for international cooperation in science, technology and innovation, advancing Target 17.6 of the SDG3 on the promotion of Universal Health Coverage.
The cooperation will initially tackle one of I-DAIR’s PathFinders projects: to foster Digital Innovations in Health Systems, and will focus more specifically on the issue of Antimicrobial Resistance (AMR). Antimicrobial Resistance causes 700,000 deaths per year globally and if left uncontrolled, is estimated to cause 10 million deaths in 2050.
Besides drug-resistant infections, AMR also impacts routine healthcare interventions, such as surgery and organ transplants. Qualified as a silent pandemic in the making, AMR represents a true global health challenge, on which I-DAIR and NCID will work together to solve. The concerted efforts will advance research aiming at digitally optimizing antibiotic therapy, while serving as a model for international collaboration.
Tan Tock Seng Hospital is one of Singapore’s largest multidisciplinary hospitals, a member of the National Healthcare Group and a provider of high quality, integrated healthcare service and the legal entity for NCID, a new state-of-the-art national centre for managing infectious diseases in Singapore.
The International Digital Health and AI Research Collaborative (I-DAIR) follows up the recommendations of the UNSG’s High-level Panel on Digital Cooperation, with the aim to foster global research collaboration in Digital Health (DH) and AI for health. I-DAIR envisions a co-created, multi-stakeholders and neutral platform facilitating access to DH and AI innovations for clinical researchers, policy makers and patients around the world, particularly in Low- and Middle-Income Countries (LMICs).